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A DESCRIPTIVE EXAMINATION OF MARIJUANA AND COCAINE USE 
AMONG EMPLOYED PERSONS AND ITS ASSOCIATION WITH WORK 
DAYS SKIPPED AND HEALTH STATUS
Padwal TB, Patel AS, Banahan BF
The University of Mississippi, Oxford, MS, USA
OBJECTIVES: To examine levels of cocaine and marijuana use among employed 
individuals and the relationship between illicit drug use and work days skipped and 
health status within different occupational types. METHODS: Self reported interview 
data from the 2008 National Survey on Drug Use and Health (n = 55,739) was 
analyzed. Employed individuals (n = 22,757) were categorized into three occupational 
types: “skilled labor” (n = 6,706), “retail industry” (n = 5,021) and “professionals” 
(n = 11,030). Comparative analysis were conducted for level of drug use, health status 
and days of work skipped within the three occupational types. RESULTS: Among 
marijuana users (4.7%), 3.2% were recreational users (<7 days marijuana used per 
month) and 1.5% were heavy users (>7days per month). “Professionals” had the 
lowest rate of heavy marijuana users (1.0%) compared to “retail industry” (1.9%) 
and “skilled labor” (2.1%) (χ² = 62.7, p < 0.001). More heavy marijuana users (1.2%) 
had skipped > 7 work days per month than recreation users (0.3%) and non-users 
(0.4%) (χ² = 120.5, p < 0.001). Irrespective of occupational type, more heavy mari-
juana users (10.4%) reported fair/poor health than recreational (6.9%) and non-users 
(7.1%) (χ² = 93.1, p < 0.001). “Professionals” had the lowest rate of cocaine use 
(0.6%), compared to “retail industry” (0.9%) and “skilled labor” (0.9%). Among 
cocaine users, “skilled labor” and “retail industry” employees skipped more work 
days compared to non-cocaine users (χ² = 8.3, p = 0.016). Irrespective of occupational 
type, a greater percentage (11.8%) of cocaine users reported fair/poor health than 
non-cocaine users (7.6%) (χ² = 32.9, p < 0.001). CONCLUSIONS: A distinct relation-
ship exists between levels of illicit drug use, work days skipped, health status 
and occupational type. “Professionals” use less illicit drugs and may have lower levels 
of loss in productivity and better health status compared to individuals in “skilled 
labor” and “retail industry”. Several interesting conclusions can be derived from these 
ﬁndings that can be used to implement and control for illicit drug use across 
industries.
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COMPUTERIZED INTERVENTIONS TO OBTAIN INDICATION 
INFORMATION FOR INPATIENT PRESCRIPTIONS: A PILOT STUDY IN 
DRUGS FREQUENTLY USED OFF-LABEL
Walton S1, Galanter W2, Tiryaki F1, Stafford RS3
1University of Illinois at Chicago, Chicago, IL, USA, 2The University of Illinois at Chicago, 
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OBJECTIVES: Linking indication and prescribed medicine is central to comparative 
effectiveness research and evidence based medicine. Little research exists regarding 
mechanisms for acquiring indications for inpatient medication use. The main objective 
of this pilot study was to assess an intervention during computerized physician order 
entry (CPOE) for gathering indications for inpatient medication use. METHODS: 
Three medications were selected based on clinical interest and likelihood of off-label 
use: the proton pump inhibitor (PPI), lansoprazole, the intravenous immune globulin 
(IVIG), Flebogamma®, and recombinant Factor VIIa (rFVIIa). Alerts were triggered 
at the time of CPOE for each medication. To minimize physician burden, alerts were 
not triggered when appropriate indications/diagnoses were already listed in the elec-
tronic problem list. The alerts requested clinicians to enter either a labeled or off-label 
indication for the medication order. The lansoprazole, IVIG, and rFVIIa interventions 
ran for 60, 175, and 93 days, while 873, 56, 25 alerts were displayed to clinicians, 
respectively. A random sample of 100 alerts was chosen for the lansoprazole analysis. 
Expert chart review was used as the actual indication gold-standard. RESULTS: For 
lansoprazole, 81 % of the medication orders were off-label and 71% were off-label 
if all indications of the PPI drug class were considered. For Flebogamma®, 100% of 
the orders were off-label and 86% were off-label when considering all indications of 
the IVIG class. All orders for rFVIIa were off-label. The match between indications 
entered through the alert system and chart review was 61% for lansoprazole, 46% 
for IVIG, and 40% for rFVIIa. CONCLUSIONS: This pilot of indication based pre-
scribing during CPOE illustrates many challenges: number of indications, coding 
(ICD9 codes are limited), and the tradeoff of information versus nuisance. The indica-
tion data generated was not highly accurate. The high rate of off-label use noted 
suggests the value of efﬁciently deﬁning prescribing indications.
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OBJECTIVES: This study aimed to examine the association of payer status with length 
of stay in patients hospitalized for injury. METHODS: A total of 1,020 hospitalization 
records related to injury in 2006 National Hospital Ambulatory Medical Care Survey-
Emergence Department Visit Data (NHAMCS-ED) were analyzed with national 
weight. A general linear model (GLM) was used to explore the association between 
payer status and length of stay, controlled for predisposing factors: age, gender, race; 
illness factors: intent type, pain, length of ED visit, total number of procedures in ED; 
and enabling factors: ownership of the hospital, and whether or not the hospital 
received any Medicaid disproportional share program funds in 2005. Multiple com-
parisons of least squared means using the self-pay group as reference group were 
adjusted based on Bonferroni’s method. Length of stay was logarithmically trans-
formed to depress its variance. RESULTS: The weighted sample size is 3,119,552. For 
33,202 patients whose primary expected sources of payment was worker compensa-
tions, the mean length of stay was 5.2 days (95% CI: 2.4–11.2); 4.9 days (95% CI: 
4.6–5.3) for 1,046,655 Medicare patients; 4.8 days (95% CI: 2.6–5.7) for 18,445 
whose expected source was no charge/charity; 4.3 days (95% CI: 3.9–4.7) for 619,854 
with Medicaid/SCHIP; 3.9 days (95% CI: 3.6–4.2) for 806,346 with private insurance; 
2.9 days (95% CI: 2.6–3.2) for 357,032 self-pay patients. The GLM ﬁt well (F = 6.33, 
p < 0.0001, R2 = 0.16) in this study. Effects of payer status, age, race and total number 
of procedures were statistically signiﬁcant (all p-values < 0.005). As to multiple com-
parisons, patients with either of Medicaid/SCHIP and private insurance stayed in 
hospital signiﬁcantly longer than self-pay patients (1.4 days, 95% CI: 1.1–1.7, p < 
0.01; 1.3 days, 95% CI: 1.1–1.6, p < 0.01, respectively). CONCLUSIONS: Payer 
status was signiﬁcantly associated with the length of stay for inpatients with injury, 
indicating a signiﬁcant variation due to health care access.
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REGIONAL INEQUALITIES IN THE UTILIZATION AND HEALTH 
INSURANCE REIMBURSEMENT OF SPA SERVICES IN HUNGARY
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OBJECTIVES: The aim of our study is to analyze the regional inequalities in the 
utilization and health insurance reimbursement of spa services in Hungary. 
METHODS: Data were derived from National Health Insurance Fund Administration 
(OEP), the only health care ﬁnancing agency in Hungary covering the year 2007. We 
analyzed the annual number of treatment episodes and its health insurance reimburse-
ment (both per 10000 population) according to the 20 Hungarian counties. We 
included the following type of spa treatments: spa pool of medical water, tub-bath of 
medical water, mud pack, medicinal weight-bath, effervescent-bath, medical health 
massage, sub-aquean spray massage, sub-aquean health care gymnastics for groups, 
complex balneotherapeutical service, health swim therapy for groups under 18. 
Results—both number of treatment episodes and health insurance reimbursement—
are calculated for 10,000 population in each county. RESULTS: A total of 8.16 million 
treatments of medical spa were done in Hungary in 2007 and OEP spent 4,434 billion 
HUF (Hungarian Forint) [US$25,687,967] for ﬁnancing these interventions. The 
national average of treatment episodes was 8033 per 10000 population while the 
average OEP reimbursement was 4,365 million HUF per 10,000 population. 
The detailed analysis of counties resulted in high geographical differences. We found 
the highest number of utilization in county Csongrad (treatment episodes: 15,193; 
reimbursement: 7,647 million HUF), in county Hajdu-Bihar (treatment episodes: 
11,687; reimbursement: 7,193 million HUF) and in Budapest (treatment episodes: 
10,625; reimbursement: 5904 million HUF). The lowest utilization of spa services can 
be found in county Szabolcs-Szatmár-Bereg (treatment episodes: 4107, reimbursement: 
1999 million HUF) and Nograd county (treatment episodes: 4782, reimbursement: 
2497 million HUF) and Borsod-Abauj-Zemplen county (treatment episodes: 4891, 
reimbursement: 2596 million HUF). CONCLUSIONS: Our study revealed more than 
3 times higher difference both in the utilization and health insurance reimbursement 
of spa services between counties in Hungary.
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RACIAL AND ETHNIC DISPARITIES IN THE PHARMACEUTICAL COST 
UNDER MEDICARE PART D
Chen J
College of Staten Island, Staten Island, NY, USA
OBJECTIVES: Medicare Part D may have introduced new sources for racial/ethnic 
disparities in drug costs. This study is going to compare the racial and ethnic disparities 
in the pharmaceutical costs before and after the implementation of Part D in January 
2006. METHODS: Using Medical Expenditure Panel Survey from January 2004 to 
December 2007, we examine the racial (whites vs. African Americans) and ethnic 
(whites vs. Latinos) disparities among Medicare beneﬁciaries in the probability of 
taking any drug, the amount of drug cost, the probability of having any out-of-pocket 
payment (OOP), and the share of OOP to the total drug cost before and after January 
2006. Multivariate regressions models are employed to examine the adjusted racial 
and ethnic disparities in these outcomes. RESULTS: Medicare beneﬁciaries’ OOP 
sharing signiﬁcantly dropped under Part D. Latinos and African Americans paid sig-
niﬁcant lower OOP on average compared to the whites, due to their high enrollments 
in the Medicaid. Among the Medicare and Medicaid dual eligibles, Latinos were 77% 
(p < 0.001) less likely to use any drug under Part D, while the difference was not 
signiﬁcant before 2006. There were no signiﬁcant ethnic disparities in drug cost among 
non-dual eligibles under Part D. African Americans were still less likely to use any 
drug and had lower drug costs compared to whites. CONCLUSIONS: Racial dispari-
ties in drug cost still exist and have similar magnitudes under Part D compared to 
before. Signiﬁcant variations exist among the Latino dual and non-dual eligibles. 
Under Part D, ethnic disparities among non-dual eligibles disappeared, while Latino 
dual eligibles became signiﬁcantly less likely to have any drug cost compared to whites. 
Part D has reduced ethnic disparities among non-dual eligibles, but may also have 
introduced new sources of disparities for dual eligibles.
